In May 2017, Robert Mueller was tapped to lead an inquiry into Russian interference in the 2016 presidential election, coordination by foreign agents with Donald Trump's campaign, and obstruction of justice by the president. Mueller assembled a "dream team" of top prosecutors, and for the next twenty-two months, the investigation was a black box and the subject of endless anticipation and speculation--until April 2019, when the special counsel's report was released. In Where Law Ends, legendary prosecutor Andrew Weissmann--a key player in the Special Counsel's Office--finally pulls back the curtain to reveal exactly what went on inside the investigation, including the heated debates, painful deliberations, and mistakes of the team--not to mention the external efforts by the president and Attorney General William Barr to manipulate the investigation to their political ends. Weissmann puts the reader in the room as Mueller's team made their most consequential decisions, such as whether to subpoena the president, whether to conduct a full financial investigation of Trump, and whether to explicitly recommend obstruction charges against him. Weissmann also details for the first time the debilitating effects that President Trump himself had on the investigation, through his dangling of pardons and his constant threats to shut down the inquiry and fire Mueller, which left the team racing against the clock and essentially fighting with one hand tied behind their backs. In Where Law Ends, Weissmann conjures the camaraderie and esprit de corps of the investigative units led by the enigmatic Mueller, a distinguished public servant who is revealed here, in a way we have never seen him before, as a manager, a colleague, and a very human presence. Weissmann is as candid about the team's mistakes as he is about its successes, and is committed to accurately documenting the historic investigation for future generations to assess and learn from. Ultimately, Where Law Ends is a story about a team of public servants, dedicated to the rule of law, tasked with investigating a president who did everything he could to stand in their way.

"Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. Pharma introduces brilliant scientists, in-corruptible government regulators, and brave whistleblowers facing off against company executives often blinded by greed. A business that profits from treating ills can create far deadlier problems than it cures. Addictive products are part of the industry's DNA, from the days when corner drugstores sold morphine, heroin, and cocaine, to the past two decades of dangerously overprescribed opioids. Pharma also uncovers the real story of the Sacklers, the family that became one of America's wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the center of the opioid crisis. Relying on thousands of pages of government and corporate archives, dozens of hours of interviews with insiders, and previously classified FBI files, Posner exposes the secrets of the Sacklers' rise to power--revelations that have long been buried under a byzantine web of interlocking companies with ever-changing names and hidden owners. The unexpected twists and turns of the Sackler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. Pharma reveals how and why American drug companies have put earnings ahead of patients." -- Publisher's description

Tobacco companies had been protecting their turf for decades. They had congressmen in their pocket. They had corrupt scientists who made excuses about nicotine, cancer and addiction. They had hordes of lawyers to threaten anyone—inside the industry or out—who posed a problem. They had a whole lot of money to spend. And they were good at getting people to do what they wanted them to do. After all, they had already convinced millions of Americans to take up an addictive, unhealthy, and potentially deadly habit. David Kessler didn't care about all that. In this book he tells for the first time the thrilling detective story of how the underdog FDA—while safeguarding the nation's food, drugs, and blood supply—finally decided to take on one of the world's most powerful opponents, and how it won. Like A Civil Action or And the Band Played On, A Question of Intent weaves together science, law, and fascinating characters to tell an important and often unexpectedly moving story. We follow Kessler's team of investigators as they race to find the clues that will allow the FDA to assert jurisdiction over cigarettes, while the tobacco companies and their lawyers fight back—hard. Full of insider information and drama, told with wit, and animated by its author's moral passion, A Question of Intent reads like a Grisham thriller, with one exception—everything in it is true.